Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms. Issue 11 (November 2018)

• Record Type: Journal Article
• Authors: Hoang, Phuc; Dobbins, Sara; Cornish, Alex; Chubb, Daniel; Law, Philip; Kaiser, Martin; Houlston, Richard
• Is Part Of: Leukemia. Volume 32:Issue 11(2018)
• Page Start: 2459
• Page End: 2470
• Publication Date: 2018-11
• Subjects: Leukemia -- Periodicals; 616.99419
• DOI: 10.1038/s41375-018-0103-3
• Languages: English
• ISSNs: 0887-6924

Abstract

Abstract Multiple myeloma (MM) is a biologically heterogeneous malignancy, however, the mechanisms underlying this complexity are incompletely understood. We report an analysis of the whole-genome sequencing of 765 MM patients from CoMMpass. By employing promoter capture Hi-C in naïve B-cells, we identifycis -regulatory elements (CREs) that represent a highly enriched subset of the non-coding genome in which to search for driver mutations. We identify regulatory regions whose mutation significantly alters the expression of genes as candidate non-coding drivers, including copy number variation (CNV) at CREs ofMYC and single-nucleotide variants (SNVs) in aPAX5 enhancer. To better inform the interplay between non-coding driver mutations with other driver mechanisms, and their respective roles in oncogenic pathways, we extended our analysis identifying coding drivers in 40 genes, including 11 novel candidates. We demonstrate the same pathways can be targeted by coding and non-coding mutations; exemplified byIRF4 andPRDM1, along withBCL6 andPAX5, genes that are central to plasma cell differentiation. This study reveals new insights into the complex genetic alterations driving MM development and an enhanced understanding of oncogenic pathways.